News

Neuland Laboratories Limited has submitted a certificate to the Bombay Stock Exchange and the National Stock Exchange, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, with Kfin Technologies Limited acting as the Registrar and Share Transfer Agent.

Neuland Laboratories Limited will close its trading window for equity shares from October 1, 2026, until 48 hours after the financial results for the quarter and half year ended September 30, 2026, are declared to the stock exchanges, according to a filing with the BSE Limited and the National Stock Exchange of India Ltd.

Net profit of Neuland Laboratories rose 962.37% to Rs 147.67 crore in the quarter ended June 2026 as against Rs 13.90 crore during the previous quarter ended June 2025. Sales rose 119.16% to Rs 641.58 crore in the quarter ended June 2026 as against Rs 292.75 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales641.58292.75 119 OPM %34.7411.78 - PBDT224.4137.76 494 PBT197.8517.57 1026 NP147.6713.90 962 Powered by Capital Market - Live News

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 5 August 2026.

Neuland Laboratories has received affirmation in credit ratings for bank facilities at IND A+/ Positive / IND A1.